ExeVir Bio

ExeVir Bio

Develops single-domain antibody-based therapies that help patients ward off viral infections.

Launch date
Employees
Market cap
-
Enterprise valuation
€123m (Public information from Mar 2021)
Company register number 0750.495.334
Ghent East Flanders (HQ)
Authorizing premium user...